Answers are grounded in this paper and cite their sources.
Fig. 1 The slow-release dexamethasone in proliferative vitreoretinopathy (PVR) prospective, randomized controlled clinical trial showed that a slow-release Dexamethasone injection given at the time of vitrectomy surgery and repeated at the time of oil removal does not increase the anatomic success rate at 6 months in eyes with rhegmatogenous retinal detachment with grade C PVR. There was also no change in visual acuity, however there was a statistical reduction in cystoid macular oedema. CI confidence interval. Full size image
No takes yet. Share an insight, caveat, or question.
Mostafa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: